Burleson Tess
SEC CIK 1769749 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DCOY | Decoy Therapeutics Inc. | Dir | 2,002 | $4,986 | — | 3 | 2022-06-07 | 2026-08-31 |
Most active insiders at DCOY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Rosenblum Mark J | CFO, EVP Fin | $16.0K | — |
| 2 | HANISH ARNOLD C | Dir | $3,750 | $17.28 |
| 3 | Gauthier Patricia G. | Dir | — | — |
| 4 | Marschel Peter Klaus | Chief Business Off | — | — |
| 5 | Hibner Barbara Louise | CSO | — | — |
| 6 | Burleson Tess | Dir | — | — |
| 7 | McVicar William K. | Dir | — | — |
| 8 | Lammers Paul | Dir | — | — |
| 9 | Lieber Jonathan I | Dir | — | — |
| 10 | PIERCE FREDERICK II | CEO | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-02 17:41 | 2026-08-31 | DCOY | Decoy Therapeutics Inc. | Burleson Tess | Dir | A - Grant | $0.00 | +2,000 | 2,002 | +100,000% | $0 | |
| 2023-01-05 | 2023-01-03 | DCOY | Decoy Therapeutics Inc. | Burleson Tess | Dir | A - Grant | $0.00 | +1,440 | 2,722 | +112% | $0 | |
| 2022-06-08 | 2022-06-07 | DCOY | Decoy Therapeutics Inc. | Burleson Tess | Dir | P - Purchase | $0.18 | +27.7K | 32.0K | +637% | +$4,986 |
Purchase Sale Sale after option exercise All abbreviations